F · Healthcare

Atossa Therapeutics Inc (YAG2)

Biotechnology

Atossa Therapeutics Inc (YAG2) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for YAG2

P/E ratio

25.00

Atossa Therapeutics Inc (YAG2) — FAQ

What is YAG2's P/E ratio?

The price-to-earnings (P/E) ratio for Atossa Therapeutics Inc (YAG2) is 25.00 (data as of 2026-05-23).

Does Atossa Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Atossa Therapeutics Inc (YAG2). Check the MyAverix Finance app for the latest dividend data.

What sector is Atossa Therapeutics Inc in?

Atossa Therapeutics Inc (YAG2) is classified in the Healthcare sector (Biotechnology industry).

What exchange is YAG2 listed on?

YAG2 is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)